Acute Intermittent Porphyria Market Forecast 2025-2034: Pipeline Progress and Commercial Potential
Acute Intermittent Porphyria (AIP) is gaining renewed attention across the rare disease space, and the US Acute Intermittent Porphyria Market is expected to sustain a steady compound annual growth rate through the 2025–2034 forecast window. This momentum is being fueled by earlier diagnosis through genetic testing, wider adoption of RNA interference therapies, and supportive regulatory...
0 Commentarios 0 Acciones 29 Views 0 Vista previa